This is an open access article under the terms of the Creat ive Commo ns Attri butio n-NonCo mmerc ial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
The taxonomic affinity of the near-flightless Zapata Rail Cyanolimnas cerverai, a critically endangered and highly localized species endemic to Cuba, has long been debated. Morphological analyses have suggested that this species, which constitutes a monotypic genus, could be related either to the extinct Tahitian Cave Rails (Nesotrochis sp.) or to the South American rail tribe Pardirallini, i.e., the genera Neocrex, Mustelirallus, and Pardirallus. While pronounced phenotypic convergence—and divergence—among rails have repeatedly proven morphology-based phylogenies unreliable, thus far no attempt to sequence DNA from the enigmatic Cyanolimnas has succeeded. In this study, we extracted historic DNA from a museum specimen collected in 1927 and sequenced multiple short fragments that allowed us to assemble a partial sequence of the mitochondrial cytochrome oxidase I gene. Phylogenetic analyses confirm that Cyanolimnas belongs in tribe Pardirallini as sister to genus Neocrex, from which it diverged about 6 million years ago. Their divergence from Mustelirallus was estimated at about 9 million years ago. Based on morphology and our mitochondrial phylogeny, we conclude that it is unjustified to retain the monotypic genus Cyanolimnas and tentatively recommend that C. cerverai and the two Neocrex species are ascribed to genus Mustelirallus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.